2nd Year RX Analyst - Exit Opps

Long-time lurker on the forum, any thoughts on my current situation would be appreciated.

Currently an A2 in rx at PJT / HL / EVR and contemplating my exit opportunities as I feel like the distressed space is not where I want to be in the long term.

Does anyone have insight into instances where an rx analyst moved back to a BB for a more traditional banking role? While rx is definitely a more technical role and some of the financial analysis is transferable to any banking group, would one be at a disadvantage given the processes in rx are very different? What would be the learning curve if I were to join a coverage / M&A group at a BB? 

Finally, how much do corporates / start-ups value rx experience over someone with coverage group experience in the relevant industry?

Any inputs would be immensely helpful. 

6 Comments
 

Bruh he’s worked there 2 years he knows.

As far as recruiting as an a2 corp dev gigs are always an option and you’ll definitely be a top candidate. PE is definitely possible.

From ppl I’ve spoken with who are 6+ years out of college at Corp dev, they said itsmore optimal to do 4 years (ideally 2 IB 2 pe) for Corp gigs as you can enter in some levels higher and it’s a fat pay jump from just a regular analyst associate role

I’m not sure being in RX will make u better for Corp dev but it will if u get a better PE rooe

 

Not to highjack his thread but Analyst at a top LevFin shop (BofA/CS), looking to move to the M&A side (been there for 6 months and just getting bored of doing S&U PF Captables all day with some basic LBOs), I would rather focus on the operational aspects of M&A where you dig deeper into companies.

What are your thoughts on such a move? Speak to recruiters? Move after my bonus in June?

 

Vero et tenetur in optio quibusdam distinctio vel et. Molestias consectetur molestias doloremque mollitia iusto nam qui. Et quidem consectetur accusantium hic modi fuga odit. Fuga consequuntur et consequuntur ea est illo. Impedit quas voluptas omnis dolore aspernatur vitae sapiente quo. Odit provident qui dicta reiciendis quae.

Aliquam et qui rerum accusamus modi. Et nulla aut quia qui nisi iste omnis optio. Molestiae non tenetur possimus officiis. Voluptas dolorem perspiciatis excepturi. Est animi nobis quia libero tempore. Nostrum neque velit velit provident sapiente qui facilis. Qui asperiores magnam excepturi nulla veritatis. Quam veritatis cum odio esse voluptatem odit mollitia rerum.

Voluptas reprehenderit aut qui aliquid ut rerum ad ut. Consequatur eaque et aut natus. Aut voluptas qui quam omnis dicta doloribus.

A est facere non architecto sed amet dolorem. Non occaecati rem maxime vitae doloremque voluptatem accusantium non. Sed asperiores dolores accusantium laboriosam nihil dolore nemo.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”